These findings were supported by an in vivo investigation, where mice inoculated with mouse Lewis lung carcinoma and then treated with melittin and proapoptotic peptide (KLAKLA)2 had reduced CD206+ (M2) TAM tumor infiltration, reduced tumor growth, and angiogenesis compared to control mice (197). This evidence concerns the gene MRC1 and neoplasm.